3 completed, 1 terminated. 2 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 3 | 1 | Terminated 1 |
Follow Daniel Stephan Engeler: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Prospective Investigation Using the Expired Breath Ethanol Test Benign Prostatic Hyperplasia (BPH) | Completed | Daniel Stephan Engeler | 57 | 2014-04-01 | 2016-02-02 | |
| Prostatic Artery Embolization vs. Conventional Transurethral Prostatectomy in the Treatment of Benign Prostatic Hyperplasia Prostatic artery embolization, monopolar transurethral prostatectomy - Benign Prostatic Hyperplasia | Not applicable | Completed | Daniel Stephan Engeler | 101 | 2014-02-11 | 2022-12-07 |
| Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors Bipolar transurethral resection of the urinary bladder (PlasmaKinetic, Gyrus, Fresenius), Monopolar transurethral resection of the urinary bladder (Storz GmbH &Co., Erbotom, Purisole) - Neoplasm of Lateral Wall of Urinary Bladder | Not applicable | Completed | Daniel Stephan Engeler | 44 | 2011-10-01 | 2018-03-05 |
| Botulinum Toxin Type A for the Treatment of Male Chronic Pelvic Pain Syndrome Botulinum Toxin Type A, Placebo - Chronic Prostatitis With Chronic Pelvic Pain Syndrome, Prostatitis | Phase 3 | Terminated | Daniel Stephan Engeler | 11 | 2007-04-01 | 2014-02-03 |
Prostatic Hyperplasia (2) · Prostatitis (1) · Urinary Bladder Neoplasms (1)
Switzerland (4)
Daniel Engeler, MD (2) · Daniel S Engeler, MD (2) · Hans-Peter Schmid, MD (1)